Other BCL3 transcriptional targets include PD-L1 (Programmed Cell Death 1 Ligand 1) and CAII (Carbonic Anhydrase II) that mediate cell proliferation and resistance to alkylating agents in ovarian cancer and gliomas, respectively (29, 30). Here, CA2 is linked to ovarian cancer.